David Buchbinder
Overview
Explore the profile of David Buchbinder including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
101
Citations
1446
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kahn J, Brazauskas R, Bo-Subait S, Buchbinder D, Hamilton B, Schoemans H, et al.
Lancet Child Adolesc Health
. 2024 Sep;
8(10):740-750.
PMID: 39217999
Background: Continued advances in haematopoietic cell transplantation (HCT) for children with non-malignant diseases (NMDs) have led to a growing population of survivors in whom late occurring toxic effects remain a...
2.
Schoemans H, Burns L, Liptrott S, Murray J, Kenyon M, Barata A, et al.
Bone Marrow Transplant
. 2024 Jun;
59(9):1286-1294.
PMID: 38890544
The EBMT (European Blood and Marrow Transplantation Society) aims to connect patients, the scientific community, and other stakeholders to improve hematopoietic stem cell transplantation and cellular therapy outcomes. We performed...
3.
Davis K, Mazzenga M, Hall P, Buchbinder D, Alderfer M, Oberoi A, et al.
Pediatr Blood Cancer
. 2024 Apr;
71(7):e30993.
PMID: 38605546
Background: Siblings of youth with cancer have heightened risk for poor long-term psychosocial outcomes. Although sibling psychosocial care is a standard in pediatric oncology, this standard is among those least...
4.
Rao V, Kulm E, Grossman J, Buchbinder D, Chong H, Bradt J, et al.
Blood Adv
. 2024 Apr;
8(12):3092-3108.
PMID: 38593221
Activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS) is an inborn error of immunity that manifests as immune deficiency and dysregulation; symptoms include frequent infections and lymphoproliferation. In our dose-finding and...
5.
Vallee T, Glasmacher J, Buchner H, Arkwright P, Behrends U, Bondarenko A, et al.
Blood
. 2024 Apr;
143(24):2504-2516.
PMID: 38579284
Wiskott-Aldrich syndrome (WAS) is a multifaceted monogenic disorder with a broad disease spectrum and variable disease severity and a variety of treatment options including allogeneic hematopoietic stem cell transplantation (HSCT)...
6.
Rotz S, Bhatt N, Hamilton B, Duncan C, Aljurf M, Atsuta Y, et al.
Bone Marrow Transplant
. 2024 Feb;
59(6):717-741.
PMID: 38413823
As hematopoietic cell transplantation (HCT) and cellular therapy expand to new indications and international access improves, the volume of HCT performed annually continues to rise. Parallel improvements in HCT techniques...
7.
Rotz S, Bhatt N, Hamilton B, Duncan C, Aljurf M, Atsuta Y, et al.
Transplant Cell Ther
. 2024 Feb;
30(4):349-385.
PMID: 38413247
As hematopoietic cell transplantation (HCT) and cellular therapy expand to new indications and international access improves, the number of HCTs performed annually continues to rise. Parallel improvements in HCT techniques...
8.
Zinter M, Brazauskas R, Strom J, Chen S, Bo-Subait S, Sharma A, et al.
Blood Adv
. 2023 Dec;
8(4):1002-1017.
PMID: 38127268
Allogeneic hematopoietic cell transplantation (HCT) can be complicated by life-threatening organ toxicity and infection necessitating intensive care. Epidemiologic data have been limited by single-center studies, poor database granularity, and a...
9.
Ohlsen T, Wang H, Buchbinder D, Huang I, Desai A, Zheng Z, et al.
Cancer
. 2023 Dec;
130(7):1125-1136.
PMID: 38100563
Background: Siblings of children with cancer may experience adverse household economic consequences, but their financial outcomes in adulthood are unknown. Methods: A total of 880 siblings (aged 18-64 years) of...
10.
Taylor M, Cole S, Strom J, Brazauskas R, Baker K, Phelan R, et al.
Blood Adv
. 2023 Sep;
7(22):6830-6838.
PMID: 37773924
Patient-reported outcomes (PROs) capture subjective social determinants of health (SDOHs), which can affect health outcomes through the stress response pathway. The conserved transcriptional response to adversity (CTRA) is a stress-mediated...